ºÐÀÚ À̹Ì¡ ½ÃÀå : Á¦Ç° À¯Çüº°, ¼ÒÇÁÆ®¿þ¾î Ç÷§Æûº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Molecular Imaging Market, By Product Type, Software Platforms, By Application, By End User, By Geography
»óǰÄÚµå
:
1747566
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀåÀº 2025³â¿¡ 53¾ï 2,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 77¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁöÀÇ CAGRÀº 5.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
ºÐ¼® ¹üÀ§
ºÐ¼® »ó¼¼
±âÁØ ¿¬µµ
2024³â
½ÃÀå ±Ô¸ð(2025³â)
53¾ï 2,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø±â°£ CAGR(2025-2032³â)
5.60%
¿¹Ãø ±Ý¾×(2032³â)
77¾ï 9,000¸¸ ´Þ·¯
ºÐÀÚ À̹Ì¡Àº ÀÇ·á¿ë À̹Ì¡ÀÇ ÇÑ ºÐ¾ßÀ̸ç, »ì¾ÆÀִ ȯÀÚÀÇ ÀÇ·áÀû °ü½É ºÐÀÚ¸¦ À̹Ì¡ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ½ÉÀåÇ÷°ü, ½Å°æ, Á¾¾ç, È£Èí±â, ¼ÒÈ±â µî Æø³ÐÀº ÁúȯÀÇ Áø´Ü°ú °ü¸®¿¡ ÀÌ¿ëµË´Ï´Ù. ºÐÀÚ À̹Ì¡Àº ÇÙÀÇÇÐÀÇ ÇÑ ºÐ¾ßÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ
ºÐÀÚ À̹Ì¡¹ýÀº ´Ù¾çÇÑ À¯ÇüÀÇ ¾Ï¿¡ ´ëÇÑ Ç¥ÁØÄ¡·áÀÇ ÀϺΰ¡ µÇ°í ÀÖ½À´Ï´Ù. µû¶ó¼, Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡´Â ¾çÀüÀÚ ¹æ»ç¼± ´ÜÃþ ÃÔ¿µ(PET), ´Ü±¤ÀÚ ¹æ»ç¼± ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(SPECT), ¾çÀüÀÚ ¹æ»ç¼± ´ÜÃþ ÃÔ¿µ, ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(PET- CT), ´Ü±¤ÀÚ ¹æ»ç ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ-ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(SPECT-CT) µîÀÇ Áø´Ü Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¹Ð¾î ¿Ã °¡´É¼ºÀÌ ³ô½À´Ï´Ù. À̰ÍÀÌ, ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 6¿ù Áø´Ü ¿µ»ó ½Ã½ºÅÛÀÇ ¼±µµÀû °ø±Þ¾÷üÀΠij³í ¸ÞµðÄà ½Ã½ºÅÛÁî(Canon Medical Systems USA Inc.)´Â Ä«Å׽ÿ ÇÁ¶óÀÓ µðÁöÅÐ PET/CT ½Ã½ºÅÛ¿¡ »ç¿ëµÇ´Â µö·¯´× À籸¼º(DLR) ±â¼ú ¹× °í±Þ Áö´ÉÇü Ŭ¸®¾î-IQ ¿£Áø(AiCE)ÀÌ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ 510(k) Çã°¡¸¦ ȹµæÇß½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÁÖ¿ä Æ¯Â¡
º» º¸°í¼´Â ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¡¤CAGRÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ °¢ ºÎ¹®ÀÇ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÇô ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ ¸ÅÆ®¸¯½º¿¡ ´ëÇØ ¼³¸íÇϰí ÀÖ½À´Ï´Ù. ¶Ç, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎÀ̳ª ±âȸ, ½ÅÁ¦Ç°ÀÇ Ãâ½Ã³ª ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù. ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå¿¡ ÀÖ¾î¼ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ», ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿äÇÑ ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ÀÌÇÏÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±Ù°ÅÇØ Á¦°øÇÕ´Ï´Ù. º» º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÀÌ¿ëÇØ, ¸¶ÄÉÆÃ ´ã´çÀÚ³ª ±â¾÷ÀÇ °æ¿µÁøÀÌ, ÇâÈÄ Á¦Ç° ¹ß¸Å¡¤Á¦ÈÞ¡¤½ÃÀå È®´ë¡¤¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ, ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ¡¸¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀ塹º¸°í¼´Â ÅõÀÚÀÚ, °ø±ÞÀÚ, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî, ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ, ÀÇ»ç °áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ºÐ¼® ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
º¸°í¼ ¼³¸í
ÁÖ¿ä ¿ä¾à
Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇС¤±ÔÁ¦¡¤µ¿ÇâÀÇ ºÐ¼®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
¿ªÇÐ
±â¾÷ ÇÕº´¡¤Àμö(M&A), »ç¾÷ Çù·Â
±ÔÁ¦ ½Ã³ª¸®¿À
ÁÖ¿ä ¹ßÀü
PEST ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå : ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) À¯ÇàÀÇ ¿µÇâ
COVID-19ÀÇ ¿ªÇÐ
°ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
°æÁ¦¿¡ ¹ÌÄ¡´Â ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2032³â)
µð¹ÙÀ̽º
¼ÒÇÁÆ®¿þ¾î Ç÷§Æû
Á¦6Àå ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå : ¿ëµµº°(2020-2032³â)
½ÉÇ÷°ü
½Å°æÇÐ
Á¾¾çÇÐ
È£Èí±â
ˤˌ
±âŸ ¿ëµµ
Á¦7Àå ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2032³â)
º´¿ø
Áø´Ü À̹ÌÁö ¼¾ÅÍ
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
Á¦8Àå ¼¼°èÀÇ ºÐÀÚ À̹Ì¡ ½ÃÀå : Áö¿ªº°(2020-2032³â)
ºÏ¹Ì
À¯·´
¿µ±¹
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
ÇÁ¶û½º
½ºÆäÀÎ
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
Áß±¹
Àεµ
ÀϺ»
ASEAN
È£ÁÖ
Çѱ¹
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä«
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
秵¾ÆÇÁ¸®Ä«
ºÏ¾ÆÇÁ¸®Ä«
Áß¾Ó ¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
±â¾÷ ÇÁ·ÎÆÄÀÏ
GE Healthcare
Bruker Corporation
Fujifilm Holdings Corp.
Siemens Healthineers
Koninklijke Philips NV
Canon Medical Systems Corporation
United Imaging Healthcare Co. Ltd.
Mediso Kft.
Positron Corporation
Esaote SpA
Carestream Health
Mirada Medical Limited
Hermes Medical Solutions
Á¦10Àå ¼½¼Ç
KTH
¿µ¹® ¸ñÂ÷
Global molecular imaging market is estimated to be valued at USD 5.32 Bn in 2025 and is expected to reach USD 7.79 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 5.32 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
5.60%
2032 Value Projection:
USD 7.79 Bn
Molecular imaging is an area of medical imaging that focuses on imaging molecules of medical concern in living patients. It is integrated advanced imaging technology with molecular and cellular biology. It is safe, noninvasive, and painless procedure that is used to diagnose and manage a wide range of diseases such as cardiovascular, neurology, oncology, respiratory, and gastrointestinal. Molecular imaging is field of nuclear medicine. It includes small amount of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Moreover, molecular imaging helps to physician to disease management and improve personalize patient care.
Market Dynamics
Molecular imaging has become a part of the standard care for various types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has significantly impacted the clinical management of cancer. Thus, increasing awareness of the early diagnosis is likely to boost the demand for diagnostic products such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), positron emission tomography-computed tomography (PET-CT), single-photon emission computed tomography-computed tomography (SPECT-CT), etc. This, in turn, is expected to drive the global molecular imaging market growth. Moreover, a surge in the adoption of technologically advanced products is expected to drive the market growth. For instance, in June 2021, a leading provider of diagnostic imaging systems Canon Medical Systems USA Inc. a leading provider of diagnostic imaging systems, deep Learning Reconstruction (DLR) technology and Advanced intelligent Clear-IQ Engine (AiCE), both used in Cartesion Prime Digital PET/CT system, received 510(k) clearance from the U.S. Food and Drugs Administration (FDA). The Cartesion Prime with AiCE help clinicians consistently and routinely produce high-quality images.
Key features of the study:
This report provides an in-depth analysis of the global molecular imaging market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global molecular imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, UNITED IMAGING HEALTHCARE CO., LTD., Mediso kft., Positron Corporation, ESAOTE S.P.A., Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market.
Market Segmentation
Global Molecular Imaging Market, By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography- Computed Tomography (PET-CT)
Positron Emission Tomography- Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
Global Molecular Imaging Market, By Application:
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
Global Molecular Imaging Market, By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Global Molecular Imaging Market, By Region:
North America
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
U.S.
Canada
Latin America
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country
GCC
Israel
Rest of Middle East
Africa
By Product Type
Devices
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products
Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography - Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
Software Platforms
On Premises Solutions
Cloud Based Solutions
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
Other Applications
By End User
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
GE Healthcare
Bruker Corporation
Fujifilm Holdings Corp.
Siemens Healthineers
Koninklijke Philips N.V.
Canon Medical Systems Corporation
UNITED IMAGING HEALTHCARE CO., LTD.
Mediso kft.
Positron Corporation
ESAOTE S.P.A.
Carestream Health
Mirada Medical Limited
Hermes Medical Solutions
Table of Contents
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Molecular Imaging Market - COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Molecular Imaging Market, By Product Type, 2020- 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Hybrid Products ( Positron Emission Tomography - Computed Tomography (PET-CT)
Positron Emission Tomography- Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR))
Software Platforms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
On Premises Solutions
Cloud Based Solutions
6. Global Molecular Imaging Market, By Application, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Respiratory
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Gastrointestinal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Other Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
7. Global Molecular Imaging Market, By End User, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Diagnostic Imaging Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
8. Global Molecular Imaging Market, By Region, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
North America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
Europe
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast,Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Region/Country, 2020 -2032, (US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
GE Healthcare
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Bruker Corporation
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Fujifilm Holdings Corp.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Siemens Healthineers
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Koninklijke Philips N.V.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Canon Medical Systems Corporation
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
United Imaging Healthcare Co., Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Mediso Kft.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Positron Corporation
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Esaote SpA
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Carestream Health
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Mirada Medical Limited
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Hermes Medical Solutions
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
10. Section
References
Research Methodology
About us and Sales Contact
°ü·ÃÀÚ·á